XML 77 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Previously Reported
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Shares
Common Shares
Previously Reported
Reserves
Reserves
Previously Reported
AOCI
Retained Earnings (Deficit)
Retained Earnings (Deficit)
Previously Reported
Retained Earnings (Deficit)
Revision of Prior Period, Accounting Standards Update, Adjustment
Beginning balance (in shares) at Dec. 31, 2019       113,452,363              
Beginning balance at Dec. 31, 2019 $ 403,059     $ 505,686   $ 27,959     $ (130,586)    
Shares and options issued on acquisition (in shares)       94,635,765              
Shares and options issued on acquisition 751,819     $ 732,042   19,777          
Shares issued in private placements (in shares)       6,934,438              
Shares issued in private placements 42,855     $ 42,855              
Equity component of Convertible Notes issued 8,322         8,322          
Shares issued on exercise of warrants and stock options, and settlement of RSUs and pRSUs (in shares)       27,331,840              
Shares issued on exercise of warrants and stock options, and settlement of RSUs and pRSUs 215,417     $ 237,521   (22,104)          
Share-based compensation 4,825         4,825          
Share issue costs (62)     $ (62)              
Net income and total comprehensive income 20,720               20,720    
Net income and total comprehensive income 22,288                    
Ending Balance (in shares) at Dec. 31, 2020       242,354,406 242,354,406            
Ending Balance at Dec. 31, 2020 1,448,523 $ 1,446,955 $ 1,568 $ 1,518,042 $ 1,518,042 38,779 $ 38,779   (108,298) $ (109,866) $ 1,568
Shares and options issued on acquisition (in shares)       47,373,723              
Shares and options issued on acquisition 407,768     $ 399,613   8,155          
Shares issued in private placements (in shares)       7,500,000              
Shares issued in private placements 59,595     $ 59,595              
Shares issued on exercise of warrants and stock options, and settlement of RSUs and pRSUs (in shares)       4,096,475              
Shares issued on exercise of warrants and stock options, and settlement of RSUs and pRSUs 21,755     $ 29,624   (7,869)          
Share-based compensation 7,973         7,973          
Share issue costs (97)     $ (97)              
Net income and total comprehensive income 639,828             $ 84,939 554,889    
Ending Balance (in shares) at Dec. 31, 2021       301,324,604              
Ending Balance at Dec. 31, 2021 $ 2,585,345     $ 2,006,777   $ 47,038   $ 84,939 $ 446,591